The aim of this post hoc analysis of data extracted from a prospective, multicenter study is to test in a large homogenous population of chemotherapy-naïve patients with colorectal cancer (CRC) treated with oxaliplatin (OXA)-based chemotherapy whether advanced age increases the risk of developing OXA-induced peripheral neuropathy (OXAIPN)
Argyriou, A., Briani, C., Cavaletti, G., Bruna, J., Alberti, P., Velasco, R., et al. (2013). Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study. EUROPEAN JOURNAL OF NEUROLOGY, 20(5), 788-794 [10.1111/ene.12061].
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study
CAVALETTI, GUIDO ANGELO;ALBERTI, PAOLA;Cortinovis, D;Cazzaniga, M;
2013
Abstract
The aim of this post hoc analysis of data extracted from a prospective, multicenter study is to test in a large homogenous population of chemotherapy-naïve patients with colorectal cancer (CRC) treated with oxaliplatin (OXA)-based chemotherapy whether advanced age increases the risk of developing OXA-induced peripheral neuropathy (OXAIPN)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
